|
Title
|
Publication Date
|
Price
|
Relevance
|
Innovations In Epigenetics
Advances in Technologies, Diagnostics & Therapeutics
|
Nov 2009 |
£2,425 |
100% |
|
Analytical Tool - Targeted Therapeutics: Melanoma
|
Jan 2010 |
£2,575 |
99% |
Epigenetics
Current and future applications that are driving novel drug discovery
|
Aug 2010 |
£695 |
99% |
Innovations in Cancer
Novel Therapeutics, New Diagnostics and Future R&D Strategies
|
Feb 2007 |
£1,820 |
99% |
|
Analytical Tool - Current & Future Lung Cancer Therapeutics
|
May 2007 |
£2,575 |
98% |
|
Systemic Fungal Infection Therapeutics Market- Taiwan
|
Nov 2009 |
£3,795 |
97% |
Delivering RNAi-Based Therapeutics & Diagnostics
Challenges & Opportunities
|
Jul 2009 |
£945 |
97% |
Outlook for RNAi, 2007
siRNA and miRNA in biology, diagnostics and therapeutics
|
Jun 2007 |
£1,820 |
97% |
|
Systemic Fungal Infection Therapeutics Market - Singapore
|
Nov 2009 |
£3,795 |
97% |
|
Systemic Fungal Infection Therapeutics Market - Australia
|
Nov 2009 |
£3,795 |
97% |
Analytical Tool - Targeted Therapeutics: Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
|
May 2007 |
£2,615 |
96% |
Ion Channel Drug Discovery
Therapeutic Opportunities & Technology Progress
|
May 2004 |
£830 |
96% |
The Future of the Biologicals Market
Market overview, innovations and company profiles
|
Mar 2010 |
£2,425 |
96% |
|
Melanoma Therapeutics
|
Apr 2010 |
£2,500 |
96% |
Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine
Lack of Market Prospects for Biologics Expose An Opportunity for Cell and Gene Therapies
|
Jul 2008 |
£4,805 |
96% |
Breast Cancer
Therapeutic And Competitive Insights
|
Feb 2007 |
£1,295 |
96% |
|
Systemic Fungal Infection Therapeutics Research - Malaysia
|
Oct 2009 |
£3,795 |
95% |
|
Targeted Therapeutics in Non-Small Cell Lung Cancer
|
Apr 2007 |
£1,295 |
95% |
|
RNA interference (RNAi)
|
Apr 2011 |
£3,035 |
95% |
Stakeholder Opinions: Therapeutic Vaccines
A far-off promise of greatness
|
Dec 2009 |
£2,405 |
95% |
Rigshospitalet – Developmental Therapeutics Review
Q4 2010
|
Nov 2010 |
£315 |
95% |
PETHEMA – Developmental Therapeutics Review
Q4 2010
|
Nov 2010 |
£315 |
95% |
|
Hematological Cancers - A Therapeutic & Competitive Insight
|
Oct 2006 |
£2,450 |
95% |
Acne
Pipeline Assessment and Market Forecasts to 2017
|
Jul 2010 |
£1,265 |
95% |
|
Global Protein Therapeutics Market Analysis
|
Jul 2011 |
£1,140 |
95% |
Type 2 Diabetes
Pipeline Assessment and Market Forecasts to 2017
|
Aug 2010 |
£1,265 |
95% |
|
Systemic Fungal Infection Therapeutics Market - India
|
Nov 2009 |
£3,795 |
95% |
|
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics
|
Apr 2008 |
£1,870 |
94% |
|
Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market
|
Feb 2011 |
£2,215 |
94% |
|
Systemic Fungal Infection Therapeutics Market - China
|
Nov 2009 |
£3,795 |
94% |
